EZH2 and meningioma: The absence of H3K27me3 expression in meningiomas is currently considered to be a poor prognostic factor (Katz et al., 2018; Nassiri et al., 2021), but studies on EZH2 in meningiomas are still rare (Samal et al., 2020).